Cenegermin Completed Phase 4 Trials for Neurotrophic Keratopathy Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04485546 | Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis |